250 related articles for article (PubMed ID: 16542836)
1. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
Dalakas MC
Neuromuscul Disord; 2006 Apr; 16(4):223-36. PubMed ID: 16542836
[No Abstract] [Full Text] [Related]
2. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approaches in patients with inflammatory myopathies.
Dalakas MC
Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
Pongratz D
J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
[TBL] [Abstract][Full Text] [Related]
5. Biologic therapy in the idiopathic inflammatory myopathies.
Khoo T; Limaye V
Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
[TBL] [Abstract][Full Text] [Related]
6. Treatment of idiopathic inflammatory myopathies.
Amato AA; Griggs RC
Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
[TBL] [Abstract][Full Text] [Related]
7. Polymyositis and dermatomyositis.
Dalakas MC; Hohlfeld R
Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
[TBL] [Abstract][Full Text] [Related]
8. The molecular pathophysiology in inflammatory myopathies.
Dalakas MC
Rev Med Interne; 2004 Jun; 25 Suppl 1():S14-6. PubMed ID: 15165685
[No Abstract] [Full Text] [Related]
9. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
10. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.
Bae SS; Lee YY; Shahbazian A; Wang J; Meriwether D; Golub I; Oganesian B; Dowd T; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2020 Nov; 59(11):3515-3525. PubMed ID: 32830270
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous immunoglobulins in chronic idiopathic myositis].
Michels H; Burmester GR; Buttgereit F
Z Rheumatol; 2005 Mar; 64(2):102-10. PubMed ID: 15793676
[No Abstract] [Full Text] [Related]
12. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
13. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
14. Use of methotrexate in inflammatory myopathies.
Fendler C; Braun J
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic targets for idiopathic inflammatory myopathies.
De Bleecker JL; Creus KK; De Paepe B
Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in Myositis and Scleroderma.
Postolova A; Chen JK; Chung L
Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
[TBL] [Abstract][Full Text] [Related]
17. [Current therapy for polymyositis and dermatomyositis].
Chérin P
Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of myositis: issues, concerns and future prospects.
Dalakas MC
Nat Rev Rheumatol; 2010 Mar; 6(3):129-37. PubMed ID: 20125096
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in the treatment of inflammatory myopathies: a review.
Fasano S; Gordon P; Hajji R; Loyo E; Isenberg DA
Rheumatology (Oxford); 2017 Jan; 56(1):26-36. PubMed ID: 27121778
[TBL] [Abstract][Full Text] [Related]
20. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
Rider LG; Katz JD; Jones OY
Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
